Arkema Sa Adr Stock Current Liabilities
ARKAY Stock | USD 100.42 0.08 0.08% |
Arkema SA ADR fundamentals help investors to digest information that contributes to Arkema SA's financial success or failures. It also enables traders to predict the movement of Arkema Pink Sheet. The fundamental analysis module provides a way to measure Arkema SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arkema SA pink sheet.
Arkema |
Arkema Current Liabilities Analysis
Arkema SA's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Arkema SA Current Liabilities | 1.48 B |
Most of Arkema SA's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arkema SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
In accordance with the recently published financial statements, Arkema SA ADR has a Current Liabilities of 1.48 B. This is 76.17% lower than that of the Basic Materials sector and 75.49% higher than that of the Specialty Chemicals industry. The current liabilities for all United States stocks is 81.33% higher than that of the company.
Arkema Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arkema SA's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Arkema SA could also be used in its relative valuation, which is a method of valuing Arkema SA by comparing valuation metrics of similar companies.Arkema SA is currently under evaluation in current liabilities category among related companies.
Arkema Fundamentals
Return On Equity | 0.15 | |||
Return On Asset | 0.0333 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.06 % | |||
Current Valuation | 8.73 B | |||
Shares Outstanding | 74.81 M | |||
Shares Owned By Institutions | 0.03 % | |||
Price To Earning | 18.63 X | |||
Price To Book | 0.82 X | |||
Price To Sales | 0.58 X | |||
Revenue | 9.52 B | |||
Gross Profit | 2.14 B | |||
EBITDA | 2.54 B | |||
Net Income | 1.31 B | |||
Cash And Equivalents | 1.34 B | |||
Cash Per Share | 18.14 X | |||
Total Debt | 2.56 B | |||
Debt To Equity | 0.47 % | |||
Current Ratio | 1.90 X | |||
Book Value Per Share | 105.12 X | |||
Cash Flow From Operations | 915 M | |||
Earnings Per Share | 15.24 X | |||
Price To Earnings To Growth | 0.77 X | |||
Target Price | 110.28 | |||
Number Of Employees | 20.2 K | |||
Beta | 1.27 | |||
Market Capitalization | 7.51 B | |||
Total Asset | 12.3 B | |||
Retained Earnings | 1.21 B | |||
Working Capital | 1.92 B | |||
Current Asset | 3.4 B | |||
Current Liabilities | 1.48 B | |||
Z Score | 1.2 | |||
Annual Yield | 0.03 % | |||
Five Year Return | 2.57 % | |||
Net Asset | 12.3 B | |||
Last Dividend Paid | 3.0 |
About Arkema SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arkema SA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arkema SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arkema SA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema ADR operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.
Pair Trading with Arkema SA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arkema SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arkema SA will appreciate offsetting losses from the drop in the long position's value.Moving against Arkema Pink Sheet
0.64 | ROBOF | RoboGroup TEK | PairCorr |
0.58 | ECL | Ecolab Inc Financial Report 7th of May 2024 | PairCorr |
0.51 | SHW | Sherwin-Williams Fiscal Quarter End 31st of March 2024 | PairCorr |
0.5 | CDIV | Cascadia Investments | PairCorr |
0.49 | TLLYF | Trilogy International | PairCorr |
The ability to find closely correlated positions to Arkema SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arkema SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arkema SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arkema SA ADR to buy it.
The correlation of Arkema SA is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arkema SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arkema SA ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arkema SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Arkema SA Piotroski F Score and Arkema SA Altman Z Score analysis. Note that the Arkema SA ADR information on this page should be used as a complementary analysis to other Arkema SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Arkema Pink Sheet analysis
When running Arkema SA's price analysis, check to measure Arkema SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema SA is operating at the current time. Most of Arkema SA's value examination focuses on studying past and present price action to predict the probability of Arkema SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arkema SA's price. Additionally, you may evaluate how the addition of Arkema SA to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data |